Table 2 Indications for MRCP in the two groups of patients.
Indication | Group 1 glass (N = 308) | Group 2 glasses (N = 305) | P |
|---|---|---|---|
Gallstones | 83 (26.9%) | 88 (28.9%) | 0.653 |
Primary sclerosing cholangitis | 48 (15.6%) | 56 (18.4%) | 0.390 |
Intraductal papillary mucinous neoplasm | 114 (37%) | 98 (32.1%) | 0.234 |
Preoperative biliary anatomy evaluation | 2 (0.6%) | 8 (2.6%) | 0.062 |
Liver transplantation | 19 (6.2%) | 22 (7.2%) | 0.631 |
Others | 42 (13.6%) | 33 (10.8%) | 0.325 |